Dr. Casilda Balmaceda, cb116@columbia.edu
Studies of primary brain tumors including gliomas, oligodendrogliomas, lymphomas and pineal tumors; leptomeningeal tumors; paraneoplastic syndromes. Multicenter clinical trials of new therapeutic agents.
Rose Lai, M.D., rl207@columbia.edu
The molecular epidemiology of brain tumors. Population-based studies to elucidate different genetic polymorphisms and their role in the pathogenesis of brain tumors, especially glioma. Using metabolic imaging techniques to identify molecular markers in brain tumors and predict responsiveness to treatment.
Steven Rosenfeld, M.D., Ph.D., sr2327@columbia.edu
Director, NYPH Brain Tumor Center
Novel ways of pharmacologically-blocking brain tumor growth and invasiveness by targeting the molecular motors that drive mitosis and cell motility.